Mariasole Bruno

Mariasole Bruno

Auto-generated profile, based on publicly available information

Mariasole Bruno

D Department of Molecular Medicine and Medical Biotechnology , University Federico II , Naples , Italy

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in Antioxidants & Redox Signaling
Verified
Journal Article
Open access
AMAlessandro Matte
Alessandro Matte
LFLuigia De Falco
Luigia De Falco
AIAchille Iolascon
Achille Iolascon
NMNarla Mohandas
Narla Mohandas
XAXiuli An
Xiuli An
LFLucia De Franceschi
Lucia De Franceschi
Aims: β-Thalassemia is a common inherited red cell disorder characterized by ineffective erythropoiesis and severe oxidative stress. Peroxiredoxin-2 (Prx2), a typical 2-cysteine peroxiredoxin, is upregulated during β-thalassemic erythropoiesis, but its contribution to stress erythropoiesis, a common feature of thalassemia, is yet to be fully defined. Results: Here, we showed that Prx2 −/− mice displayed reactive oxygen species related abnormalities in erythropoiesis similar to that of Hbb th3/+ mice associated with activation of redox response transcriptional factor nuclear factor-erythroid 2 (Nrf2). We generated β-thalassemic mice genetically lacking Prx2 (Prx2 −/− Hbb th3/+ ) and documented a worsened β-thalassemic hematological phenotype with severe ineffective erythropoiesis. To further validate a key role of Prx2 in stress erythropoiesis, we administrated fused recombinant PEP1Prx2 to Hbb th3/+ mice and documented a decrease in ineffective erythropoiesis. We further show that Prx2 effects are mediated by activation of Nrf2 and upregulation of genes that protect against oxidative damage such as gluthatione S-transferase, heme-oxygenase-1, and NADPH dehydrogenase quinone-1. Innovation: We propose Prx2 as a key antioxidant system and Nrf2 activation is a cellular adaptive process in response to oxidative stress, resulting in upregulation of antioxidant (antioxidant responsive element) genes required to ensure cell survival. Conclusion: Our data shed new light on adaptive mechanisms against oxidative damage through the interplay of Prx2 and Nrf2 during stress erythropoiesis and suggest new therapeutic options to decrease ineffective erythropoiesis by modulation of endogenous antioxidant systems. Antioxid. Redox Signal. 23, 1284–1297.

25 August 2014 in Human Mutation
Verified
Journal Article
Closed access
PDF file
LFLuigia De Falco
Luigia De Falco
LSLaura Silvestri
Laura Silvestri
CKCaroline Kannengiesser
Caroline Kannengiesser
EMErica Morán
Erica Morán
COClaire Oudin
Claire Oudin
MSMayka Sanchez
Mayka Sanchez

1 November 2013 in Neuroscience Research
Verified
Journal Article
Closed access
RARoberta Asci
Roberta Asci
FVFara Vallefuoco
Fara Vallefuoco
Immacolata AndolfoImmacolata Andolfo
Immacolata Andolfo
MBMariasole Bruno
Mariasole Bruno
LFLuigia De Falco
Luigia De Falco
AIAchille Iolascon
Achille Iolascon

2 April 2016 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
PDF file
ESErtan Sal
Ertan Sal
EKEbru Yılmaz Keskin
Ebru Yılmaz Keskin
IYIdil Yenicesu
Idil Yenicesu
MBMariasole Bruno
Mariasole Bruno
LFLuigia De Falco
Luigia De Falco
Iron-refractory iron deficiency anemia (IRIDA) is a rarely diagnosed autosomal recessive disorder that presents with hypochromic, microcytic anemia due to mutations in TMPRSS6, which encodes matriptase-2. Contrary to classical iron deficiency anemia, serum hepcidin levels are found to be elevated in this disorder. Here, we report 5 cases from 4 unrelated families with inadequate response to iron therapy, who were consequently diagnosed as IRIDA. The mean age of the cases at diagnosis was 5.0 years (range: 0.7–11.3 years). All cases were either homozygous or compound heterozygous for missense or frameshift mutations in the TMPRSS6 gene, 2 of the mutations being novel (Cys410Ser and Leu689Pro). IRIDA should be considered in patients with findings of iron deficiency anemia unresponsive to oral iron therapy, whose serum ferritin levels are found normal or elevated.

1 October 2015 in Seminars in Hematology
Verified
Journal Article
Closed access
MBMariasole Bruno
Mariasole Bruno
LFLuigia De Falco
Luigia De Falco
Achille IolasconAchille Iolascon
Achille Iolascon

27 September 2012 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
LFLuigia De Falco
Luigia De Falco
MBMariasole Bruno
Mariasole Bruno
Immacolata AndolfoImmacolata Andolfo
Immacolata Andolfo
BDBeneitez Pastor David
Beneitez Pastor David
DGDomenico Girelli
Domenico Girelli
Achille IolasconAchille Iolascon
Achille Iolascon
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.